[1]
“The clinical and economic value of the dipeptide alanyl-glutamine in total parenteral nutrition of critically ill patients treated in intensive care units in Italy”, FE, vol. 10, no. 2, pp. 83–92, Jun. 2009, doi: 10.7175/fe.v10i2.166.